A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

Zydus Life share price: Zydus Life shares rallied as much as 6.80 per cent to hit an intraday high of Rs 947.95 per share on Thursday, March 6, 2025. The uptick in Zydus Life share price came after ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval from the US Food and Drug Administration (USFDA) to market Dasatinib tablets ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. (USRLD: ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug Administration (USFDA) to market Dasatinib tablets in multiple strengths —20 mg, ...

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dasatinib tablets in multiple strengths, a generic version of Bristol ...